Home Cart Sign in  
Chemical Structure| 31354-48-0 Chemical Structure| 31354-48-0
Chemical Structure| 31354-48-0
Product Citations

Alternative Products

Product Details of [ 31354-48-0 ]

CAS No. :31354-48-0
Formula : C7H8N2O2
M.W : 152.15
SMILES Code : CC(NC1=NC=CC=C1O)=O
MDL No. :MFCD09757484
InChI Key :RNNMBUAVVIZMMX-UHFFFAOYSA-N
Pubchem ID :573434

Safety of [ 31354-48-0 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Calculated chemistry of [ 31354-48-0 ] Show Less

Physicochemical Properties

Num. heavy atoms 11
Num. arom. heavy atoms 6
Fraction Csp3 0.14
Num. rotatable bonds 2
Num. H-bond acceptors 3.0
Num. H-bond donors 2.0
Molar Refractivity 40.57
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

62.22 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.69
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.01
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.55
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.66
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.39
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.2

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.06
Solubility 13.2 mg/ml ; 0.0868 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-0.87
Solubility 20.6 mg/ml ; 0.135 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.82
Solubility 2.3 mg/ml ; 0.0151 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.22 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.56

Application In Synthesis [ 31354-48-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 31354-48-0 ]

[ 31354-48-0 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 31354-48-0 ]
  • [ 86467-39-2 ]
References: [1] Pharmaceutical Bulletin, 1957, vol. 5, p. 350,352.
[2] Tetrahedron Letters, 2013, vol. 54, # 48, p. 6415 - 6419.
  • 2
  • [ 114658-06-9 ]
  • [ 86467-39-2 ]
  • [ 31354-48-0 ]
  • [ 83988-39-0 ]
References: [1] Heterocycles, 1987, vol. 26, # 11, p. 2921 - 2939.
[2] Heterocycles, 1987, vol. 26, # 11, p. 2921 - 2939.
  • 3
  • [ 16867-03-1 ]
  • [ 75-36-5 ]
  • [ 31354-48-0 ]
References: [1] Tetrahedron, 2006, vol. 62, # 10, p. 2405 - 2412.
[2] Tetrahedron Letters, 2004, vol. 45, # 7, p. 1465 - 1468.
  • 4
  • [ 16867-03-1 ]
  • [ 108-24-7 ]
  • [ 31354-48-0 ]
References: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 15, p. 3730 - 3742.
  • 5
  • [ 114658-06-9 ]
  • [ 86467-39-2 ]
  • [ 31354-48-0 ]
  • [ 83988-39-0 ]
References: [1] Heterocycles, 1987, vol. 26, # 11, p. 2921 - 2939.
[2] Heterocycles, 1987, vol. 26, # 11, p. 2921 - 2939.
  • 6
  • [ 100061-12-9 ]
  • [ 31354-48-0 ]
References: [1] Pharmaceutical Bulletin, 1957, vol. 5, p. 350,352.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 31354-48-0 ]

Alcohols

Chemical Structure| 159183-89-8

A345796 [159183-89-8]

N-(5-Hydroxypyridin-2-yl)acetamide

Similarity: 0.78

Chemical Structure| 902835-93-2

A217578 [902835-93-2]

tert-Butyl (3-hydroxypyridin-2-yl)carbamate

Similarity: 0.71

Chemical Structure| 20348-16-7

A104964 [20348-16-7]

2-Amino-6-methylpyridin-3-ol

Similarity: 0.70

Chemical Structure| 79707-11-2

A379749 [79707-11-2]

2-Methylimidazo[1,2-a]pyridin-8-ol

Similarity: 0.65

Chemical Structure| 40966-87-8

A226667 [40966-87-8]

2-Amino-5-chloropyridin-3-ol

Similarity: 0.65

Amides

Chemical Structure| 20348-09-8

A120892 [20348-09-8]

2H-Pyrido[3,2-b][1,4]oxazin-3(4H)-one

Similarity: 0.85

Chemical Structure| 159183-89-8

A345796 [159183-89-8]

N-(5-Hydroxypyridin-2-yl)acetamide

Similarity: 0.78

Chemical Structure| 5221-37-4

A334847 [5221-37-4]

2-Chloro-N-pyridin-2-ylacetamide

Similarity: 0.75

Chemical Structure| 122450-96-8

A196227 [122450-96-8]

7-Bromo-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one

Similarity: 0.73

Chemical Structure| 337463-88-4

A203706 [337463-88-4]

6-Bromo-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one

Similarity: 0.73

Amines

Chemical Structure| 159183-89-8

A345796 [159183-89-8]

N-(5-Hydroxypyridin-2-yl)acetamide

Similarity: 0.78

Chemical Structure| 5221-37-4

A334847 [5221-37-4]

2-Chloro-N-pyridin-2-ylacetamide

Similarity: 0.75

Chemical Structure| 902835-93-2

A217578 [902835-93-2]

tert-Butyl (3-hydroxypyridin-2-yl)carbamate

Similarity: 0.71

Chemical Structure| 1075-62-3

A247227 [1075-62-3]

N-(6-Aminopyridin-2-yl)acetamide

Similarity: 0.71

Chemical Structure| 10201-71-5

A433092 [10201-71-5]

2-Amino-3-methoxypyridine

Similarity: 0.70

Related Parent Nucleus of
[ 31354-48-0 ]

Pyridines

Chemical Structure| 159183-89-8

A345796 [159183-89-8]

N-(5-Hydroxypyridin-2-yl)acetamide

Similarity: 0.78

Chemical Structure| 80827-67-4

A155743 [80827-67-4]

1-(3-Methoxypyridin-2-yl)piperazine

Similarity: 0.76

Chemical Structure| 5221-37-4

A334847 [5221-37-4]

2-Chloro-N-pyridin-2-ylacetamide

Similarity: 0.75

Chemical Structure| 902835-93-2

A217578 [902835-93-2]

tert-Butyl (3-hydroxypyridin-2-yl)carbamate

Similarity: 0.71

Chemical Structure| 345310-98-7

A174042 [345310-98-7]

1-(Pyridin-2-yl)piperazin-2-one

Similarity: 0.71